2013-09-26
[DIV28SUPER] Fwd: [DIV6] job listing at Temple University
> Assistant professor position in behavioral neuroscience at Temple posted on behalf of Tom Gould. Please direct questions to him at the email on the advertisement….
___________________ div28SUPER@lists.apa.org _____________________
Div28m members may post here subscribers corner: http://lists.apa.org
2013-09-24
[DIV28SUPER] Brown, Nader to keynote addictions Conference | 2014 CPA
Changing Addictive Behavior: Bench to Bedside and Back Again · SANDRA A. BROWN, PH.D. is Vice Chancellor for Research and a Distinguished Professor of Psychology and Psychiatry at the University of California, San Diego. Dr. Brown is internationally recognized for her developmentally focused alcohol and drug intervention research. She is the past President of Division 50 (Addictions) of the American Psychological Association, is on the executive board of numerous scientific organizations, and has over 320 publications. She is involved in addiction prevention and intervention at the regional, state, and national levels and helped lead NIAAA’s effort to establish national screening guidelines for youth. She currently directs the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA). · MICHAEL A. NADER, PH.D. is a Professor of Physiology and Pharmacology, Wake Forest University School of Medicine, in Winston-Salem, NC. Dr. Michael Nader’s research interest began in the laboratory of Dr. Alice Young at Wayne State University. He received his Ph.D. in 1985 from the University of Minnesota, under the mentorship of Dr. Travis Thompson and completed post-doctoral training in behavioral pharmacology at Uniformed Services University under the mentorship of Dr. James Barrett. In 1988, he went to the University of Chicago, where Dr. William Woolverton trained him in nonhuman primate models of cocaine abuse. Since 1992, Dr. Nader has been on the faculty in the Department of Physiology and Pharmacology at Wake Forest University School of Medicine, where he is Professor. His research has focused on nonhuman primate models of drug abuse, combining brain imaging with behavioral methods to better understand how environmental (including social) and pharmacological variables influence addiction. His laboratory is the only one in the world studying socially housed monkeys (male and female) in intravenous drug self-administration studies. He has served on Board of Directors of the CPDD, is past-chair of the Division of Behavioral Pharmacology at ASPET and is currently a member of NIDA Council. Dr. Nader has a MERIT Award from NIDA. PRE-CONFERENCE WORKSHOP Treating Adolescent Substance Abuse: What Works and How Can We Do It? Adolescence is an exciting period of development, as it inherently involves the exploration of identity, autonomy, sexuality, value systems, and peer relationships. Further, during this period, adolescents often “try on” different facets of adult life, including experimentation with health risk behaviors, including alcohol, cigarette, and cannabis use. This experimentation is facilitated by changes in adolescents’ social environment, which becomes increasingly peer-dominated, and has an increasing presence of alcohol and cannabis use opportunities. While many youth continue to adulthood without consequence, the substance use patterns of many adolescents interfere with their academic progress, as well as their health, personal, and social development. This workshop presents an opportunity for us to explore the state of the art of adolescent addictions research, including current empirically supported interventions. In addition, this workshop includes hands-on experience practicing foundational skills in three empirically supported intervention approaches (motivational interviewing, contingency management, and mindfulness based relapse prevention). Participants will depart with basic knowledge of, skills in, and resources to obtain further information in each clinical approach. Presenter: Sarah W. Feldstein Ewing, Ph.D., University of New Mexico, Honors College/Center on Alcoholism, Substance Abuse, and Addictions (CASAA) POSTER SESSION The priority deadline for poster proposals is October 1, 2013. Late submissions will be accepted on a limited basis. For information on submitting, visit www.tinyurl.com/2014CPAPosters. ABOUT THE CONFERENCE The theme for the 2014 conference is "Changing Addictive Behavior: Bench to Bedside and Back Again" · Atlanta, Georgia / February 28-March 1, 2014 · Thought-provoking keynotes and cross-discipline panels · Interactive environment for collaboration/networking · Several breakout session choices · Poster Sessions · Pre-conference in-depth workshops · Discounted rates for Early Career Psychologists · Student opportunities (discounted rates, special networking, etc) · You don't have to be a member of either or division or APA to attend the conference! · CE is available! ABOUT THE VENUE The beautiful W Hotel in Midtown Atlanta will be the venue for our First Annual Conference. The hotel is located in the heart of Midtown and is local to public transportation. Room rates are $159 per night. Reserve your room now! |
MORE INFORMATION Katie Witkiewitz, PhD, Co-Chair Jennifer Buckman, PhD, Co-Chair Chad Rummel, MEd, Registration and Hotel Accommodations (202-336-6121) |
2013-09-23
[DIV28SUPER] Division 28 Endorsement of Kurt F. Geisinger, Ph.D.
Last week the Executive Committee of Division 28 discussed the candidates for 2014 President-Elect of the American Psychological Association. The consensus of the Committee was that Kurt F. Geisinger, Ph.D. best represents the scientific interests and foci of the Division. As you can see from his candidate statement (http://www.apa.org/monitor/2013/05/candidates-geisinger.aspx), his campaign emphasizes a balanced approach that bridges science, practice, education, and public interest. On this page:
http://www.apa.org/monitor/2013/06/candidates-geisinger.aspx
Dr. Geisinger also proposes strengthening the scientific foundation of APA by improving the accessibility of dissemination of scientific data to the public.
Dr. Geisinger has also shown his commitment to APA by spending eight years as a Council Representative and nearly three years on the APA Board of Directors. You may read more about Dr. Geisinger at his campaign website, http://www.kurt4apa.org/campaign/.
Division 28 endorses Kurt F. Geisinger, Ph.D. for 2014 President-Elect of the American Psychological Association.
Anthony Liguori, Ph.D.
Division 28 President
Wake Forest School of Medicine
Winston-Salem, NC 27101
___________________ div28SUPER@lists.apa.org _____________________
Div28m members may post here subscribers corner: http://lists.apa.org
[DIV28SUPER] Position: Post-doctoral fellowship in Addictions, Department of Psychiatry, Yale University School of Medicine
Post-doctoral fellowship in Addictions, Department of Psychiatry, Yale University School of Medicine
Fellows will have the opportunity to work in a rich interdisciplinary and transdisciplinary research environment and be supervised by leading NIH-funded researchers with expertise in human laboratory and clinical treatment research methodologies; addictions with an emphasis on alcohol and nicotine dependence; gender-based research; behavioral pharmacology; medication development; stress reactivity; and epidemiological and policy research. Postdoctoral fellows will participate in a diverse training program including both didactic seminars (e.g., grant and scientific writing skills, career development, biostatistics) and individualized mentoring to build personalized programs of research. The successful candidate will be expected to contribute to, and develop research expertise through, the pursuit of defined research projects relevant to alcohol dependence, nicotine dependence, and sex/gender differences research. The position will be supported through an NIH training mechanism.
Applicants must have completed an MD or Ph.D. or equivalent degree in psychology, public health, pharmacology, neuroscience, or a related discipline. An interest in and experience with alcohol, tobacco, and/or gender-based research is relevant, but not necessary for acceptance.
Interested applicants should send a letter of interest, curriculum vitae, and the names of three references to: Dr. Sherry McKee; Department of Psychiatry, Yale University School of Medicine; 2 Church St. South, Suite 109; New Haven, CT 06519 or sherry.mckee@yale.edu.
US Citizenship or Permanent Residency is required and successful applicants will be required to undergo a criminal background check.
Yale University School of Medicine is an Affirmative Action/Equal Opportunity Employer
2013-09-19
[DIV28SUPER] Postdoctoral Position at University of Vermont=?windows-1252?Q?=92s?= C enter on Behavior and Health
--------------
--
Instructor
Johns Hopkins University School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
BPRU Phone: (410) 550-2254
Fax: (410) 550-0030
WARNING: E-mail sent over the Internet is not secure. Information sent by e-mail may not remain confidential.
DISCLAIMER: This e-mail is intended only for the individual to whom it is addressed. It may be used only in accordance with applicable laws. If you received this e-mail by mistake, notify the sender and destroy the e-mail
_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 join our network
[DIV28SUPER] Upcoming conference: Behavior Change, Health, and Health Disparities
See contact information below:
-------------------
Conference Announcement
Upcoming conference: Behavior Change, Health, and Health Disparities
The 1st annual conference sponsored by the Vermont Center on Behavior and Health at the University of Vermont, Brown University and the University of Kentucky, is nearly upon us - September 26th and 27th. Conference agenda can be found here: http://www.uvm.edu/medicine/behaviorandhealth/documents/BEHAVIORCHANGECONFERENCE9_1_13agenda.pdf.
We know that more people are interested in these topics than can physically attend, so we have set up a live stream of the event. We will be streaming the entire event (subject to presenter preferences), and anyone can view the stream (no log in required), at the following site:
https://new.livestream.com/VCBH/Conference
Talks should be available even after they have occurred, and do not need to be viewed live. So please feel free to join us virtually and experience some of the wonderful talks being held at this conference.--
Instructor
Johns Hopkins University School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
BPRU Phone: (410) 550-2254
Fax: (410) 550-0030
WARNING: E-mail sent over the Internet is not secure. Information sent by e-mail may not remain confidential.
DISCLAIMER: This e-mail is intended only for the individual to whom it is addressed. It may be used only in accordance with applicable laws. If you received this e-mail by mistake, notify the sender and destroy the e-mail
_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 join our network
2013-09-18
[DIV28SUPER] Upcoming NIDA and NIH events at Annual Meeting of the Society for Neuroscience, San Diego, CA
Table of Contents
I. Hold the Date for Frontiers in Addiction Research Mini-convention, Nov 8, 2013, The Westin Hotel in the Gas Lamp Quarter in San Diego
II. Other NIDA Events that will take place at the 2013 Society for Neuroscience Meeting Include:
Transitioning Beyond the Postdoc: Workshop for Early Career Investigators
SfN Minisymposium – New Insights into the Specificity and Plasticity of Reward and Aversion Encoding in the Mesolimbic System
III. Understanding New Brain Initiatives in the U.S. and Europe
IV. NIH BRAIN Initiative: Forum to Discuss Interim Report
-------------------
I. Hold the Date for Frontiers in Addiction Research Mini-convention , Nov 8, 2013, The Westin Hotel in the Gas Lamp Quarter in San Diego
The NIDA Neuroscience Consortium would like to announce our plan (pending official approvals) to hold the Frontiers in Addiction Research Mini-convention as a Satellite Session at the 2013 Society for Neuroscience annual meeting. As in past years, this meeting will provide the opportunity for you to interact with respected scientists across diverse disciplines as they describe the latest findings and discuss future directions in research related to the neuroscience of drug abuse and addiction. The mini-convention is planned for Friday, November 8, 2013 at The Westin Hotel in the Gas Lamp Quarter in San Diego. We plan to include several sessions aimed at discussing cutting edge research areas in neuroscience. Please save the date. Once we receive the official approval to hold the meeting, we will disseminate detailed information via the meeting website.
The proposed sessions include:
Emerging and Novel Aspects of Neuronal Transmission
Speakers: N.C. Spritzer, UCSD; D. L. Sabatini, Harvard; A. Wallén-Mackenzie, Uppsala University
Jacob P Waletzky Memorial Lecture
Speaker: The winner of the Jacob P. Waletzky Award and speaker will be announced at the mini-convention
Extracellular RNAs in Neuroscience: Biology, Biomarkers, and Therapeutics
Speakers: X. Breakefield, MGH; C. Wahlestedt, U. Miami; P. Kenny, Scripps FL; M. Wood, U of Oxford
Advances in High Resolution and Large Scale Imaging of Brain Networks and Circuits
Speakers: K. Deisseroth, Stanford; R. Buckner, MGH; M. Schnitzer, Stanford; J. Donoghue, Brown University
Role of the Basal Ganglia in Addiction
Speakers: M.K. Lobo, U of Maryland; A. Kreitzer, Gladstone; S. Ferguson, U of Washington; R. Costa, NIAAA
Early Career Investigators Presentations
Numerous young investigators will give very brief presentations of their research.
For additional information please contact Mary Kautz, Ph.D. (kautzm@mail.nih.gov) or Cathrine Sasek, Ph.D. (csasek@nih.gov) or visit: http://www.seiservices.com/nida/frontiers2013/
-------------------------
II. Other NIDA Events that will take place at the 2013 Society for Neuroscience Meeting Include:
Transitioning Beyond the Postdoc: Workshop for Early Career Investigators
Tuesday, November 12, 2013
6:30-9:00 pm
San Diego Marriott Marquis
Marina Ballroom Salon D
Are you at the end of your postdoc? Or are you a newly-minted independent investigator? Are you unsure of how to proceed during this transition phase? Then this is the workshop for you. There will be brief presentations on what you should consider when looking for a faculty position, how a potential employer might evaluate you (presented by the Chair of a major neuroscience department), establishing your laboratory and getting the right people there (presented by the Director of an NIH Intramural Program), and suggestions aimed at making that all-important first grant application successful from choosing the right funding mechanism to helpful hints to see you through the grant process. There will also be plenty of time for questions!
Presenters: Nancy Pilotte, Ph.D., Peter Kalivas, Ph.D., Robert Sorensen, Ph.D., and Antonello Bonci, M.D.
---------------------
SfN Minisymposium – New Insights into the Specificity and Plasticity of Reward and Aversion Encoding in the Mesolimbic System
Tuesday, November 12, 2013
8:30-11:00 am
Upper Level Meeting Room – 28A
San Diego Convention Center
Dopamine neurons in the ventral tegmental area (VTA) and one of their targets, the nucleus accumbens (NAc) are often referred to as the "brain reward system." But it has long been known that neurons in both of these areas also respond to aversive stimuli and events. With the advent of new anatomical, physiological, and behavioral approaches, a more sophisticated and complex understanding is emerging of how these brain areas produce both positive and negative motivational states in varying contexts. This symposium will highlight new approaches and findings, including the use of optogenetic and other techniques to identify and activate specific subcircuits, behavioral manipulations to alter the valence of stimuli depending on prior experience, and methods to investigate adaptations in coordinated neuronal activity. The speakers will demonstrate that recent research on the mesocorticolimbic system has moved well beyond questions such as "what does dopamine do?" Dr. Stephan Lammel will discuss the diverse functions of distinct subtypes of dopamine neurons in the VTA. Dr. Elyssa Margolis will discuss the heterogeneity of mu-opioid signaling in the VTA. Dr. Yunbok Kim will show how synchronized VTA neuronal firing changes during appetitive and aversive learning. Dr. Mitchell Roitman's presentation on dopamine signaling in the NAc also will show that the encoding of positive versus negative motivation in the NAc can be modulated by behavioral state and learning. Dr. Jocelyn Richard's talk will focus on how specific inputs from the prefrontal cortex bias motivational valence in the NAc. Finally, Dr. Mary Kay Lobo will discuss the distinct roles in motivational control of the NAc's two major outputs, the direct and indirect pathway medium spiny neurons.
Chair: Susan Volman, Ph.D., NIDA
----------------------
III. Understanding New Brain Initiatives in the U.S. and Europe
Date & Time: Monday, November 11, 2013 1:15pm - 3pm
Location: Ballroom 20 San Diego Convention Center.
The NIH has released the interim report of the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) working group. The full report is available from NIH as is the slide presentation that highlights key recommendations. NIH encourages feedback through the dedicated BRAIN feedback webpage. Please come to a panel discussion on the new brain initiative in the U.S. and Europe on November 11, 2013, 2013, November 11, 2013 1:15pm - 3pm in Ballroom 20, San Diego Convention Center.
Panelists:
Thomas R. Insel, MD
National Institute of Mental Health, National Institutes of Health
Story C. Landis, PhD
National Institute for Neurological Disorders and Stroke, National Institutes of Health
Geoffrey S. F. Ling, MD, PhD
Defense Sciences Office, Defense Advanced Research Projects Agency
Cora B. Marrett, PhD
National Science Foundation
The Special Presentation will feature a panel discussion about emerging neuroscience projects in the United States and Europe. The panel will include key leaders from the U.S. Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative and the Human Brain Project, a European Flagship program. Learn more about recent investments in brain research initiatives, the scientific foci, and the public policy implications and opportunities in neuroscience.
-----------------------
IV. NIH BRAIN Initiative: Forum to Discuss Interim Report
Date & Time: Monday, November 11, 2013 6:30pm - 8:30pm
Location: San Diego Convention Center
Room: 33C
Sponsored By: National Institutes of Health
The NIH Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative is part of a new Presidential focus aimed at revolutionizing our understanding of brain function. The BRAIN Initiative aims to develop and apply innovative technologies to produce a dynamic picture of the brain, capturing how individual cells and complex neural circuits interact in both time and space to encode information and code for behavior. Given the ambitious scope of this pioneering endeavor, it is vital that planning for the NIH BRAIN Initiative be informed by a wide range of expertise and experience. Therefore, NIH has established a working group of the Advisory Committee to the NIH Director (ACD) to articulate the scientific goals of the BRAIN Initiative and develop a multi-year scientific plan for achieving these goals, including timetables, milestones, and cost estimates. As part of this charge, the working group was asked to produce an interim report in fall 2013 containing specific recommendations on high-priority investments for Fiscal Year 2014. The focus of this event will be to seek input from the neuroscience community on this interim report to inform the final strategic plan, due to the NIH Director in June 2014.
Contact: Lyric Jorgenson
E-mail: jorgensonla@od.nih.gov
-------------------------
The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services TO UNSUBSCRIBE: send email to istserv@list.nih.govmailto:listserv@list.nih.gov,
Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L in the message body of the email - You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov 301-435-1309
2013-09-17
[DIV28SUPER] NIDA Neuroscience Update, September 17, 2013
I. Early Career Award in Chemistry of Drug Abuse and Addiction (ECHEM) (R21/R33) http://grants.nih.gov/grants/guide/pa-files/PAR-13-350.html
This announcement is intended to encourage early career chemists (or chemists new to NIH) to develop probes that aid basic research investigations on drug abuse and/or identify new or better templates as lead compounds with potential for conducting structure activity relationship (SAR)-function studies. Importantly, this includes the identification of new chemical entities (NCEs) with therapeutic potential for drug abuse and addiction.
Standard dates apply, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
II. Illuminate the Druggable Genome (IDG) –
Adaptation of Scalable Technologies to Illuminate the Druggable Genome (U01) (RFA-RM-13-010) http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-13-010.html
Development of a Knowledge Management Center for Illuminating the Druggable Genome (U54) (RFA-RM-13-011) http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-13-011.html
The IDG project is predicated on the need to fully explore the underlying biology and role in disease of genes linked to already drugged genes within the Druggable Genome. While the number of drugged targets is relatively limited, there are many more, related, genes that if more deeply investigated may define new biology and/or new therapeutic targets. The IDG project represents a new NIH Common Fund project and seeks to:
1) Develop a useful and public Knowledgebase that can be used to identify gaps in our knowledge of the Druggable Genome and prioritize where to subsequently invest resources
2) Adapt and scale technologies to rapidly illuminate the underlying biology and potential role in disease of prioritized genes
Please review these FOAs, share them with colleagues, and consider ways in which you may respond with applications. Full details on submission deadlines, application formats, review considerations, and implementation framework for the IDG may be found in the FOAs themselves. In addition, a technical assistance webinar for the Knowledge Management Center RFA will be held in early October. Information about the webinar will be posted on the IDG webpage at http://commonfund.nih.gov/IDG/.
-------------------------
The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services TO UNSUBSCRIBE: send email to istserv@list.nih.govmailto:listserv@list.nih.gov,
Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L in the message body of the email - You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov 301-435-1309
2013-09-16
[DIV28SUPER] Position in Social Neuroscience--UNL
Position of potential interest. Please share with colleagues. Thanks, Rick
University of Nebraska-Lincoln, Social Neuroscience
The Systems Biology of Social Behavior initiative in conjunction with the Center for Brain, Biology and Behavior at the University of Nebraska-Lincoln invites applications for a tenure-track Assistant Professor position in the area of social neuroscience starting fall semester 2014. The successful candidate will demonstrate evidence of a research agenda that employs a neuroscience perspective in addressing central aspects of social behavior, a record of achievement in scholarship and teaching, the potential to secure external funding, and ability to contribute to interdisciplinary research effort in the area of social behavior. Applicants should have completed a PhD in an appropriate field by August 2014. Experience with fMRI as well as a willingness to play a role in utilizing and managing fMRI resources is desirable but not required. The tenure home could be in any department of the College of Arts and Sciences. Salary, start-up package, and fringe benefits are competitive. The Center for Brain, Biology, and Behavior is housed in a new 26,000 square foot building centered around a 3 T. Siemens scanner as well as 12 high-density EEGERP, NIRS and TMS systems. The University of Nebraska is committed to a pluralistic campus community through affirmative action, equal opportunity, work-life balance and dual careers. Interested applicants must first go to the website http://employment.unl.edu requisition #F_13016, click on “Apply to this job,” and complete the form. Applicants will be asked to attach a letter of application, research and teaching statements, vita, writing sample, and the names of three references. To assure full consideration, applications should be received by October 25, 2013.
[DIV28SUPER] Postdoctoral position at the University of Nebraska-Lincoln
Dear Colleagues,
Please see the below for a postdoctoral position at the University of Nebraska-Lincoln:
Postdoctoral fellow in Behavioral Neuroscience and Behavioral Pharmacology
A postdoctoral fellow position is available immediately in the Department of Psychology at the University of Nebraska-Lincoln. We are looking for an individual with strong background in behavioral neuroscience or neuropsychopharmacology. Certain laboratory skills (e.g. stereotaxic surgery, microinjection, immunocytochemistry, western blotting, RT-PCR, etc.) are highly desirable. Applicants must have a PhD in a relevant field (e.g. psychology, neuroscience or pharmacology). The successful candidate will primarily work on a recently NIH-funded R01 project to investigate the behavioral and neurobiological mechanisms of maternal behavior in rodents. The individual could also participate in other ongoing research projects in the laboratory (e.g. psychopharmacology of antipsychotics, co-morbidity of nicotine addiction in schizophrenia, etc.). Qualified applicants should e-mail a cover letter, curriculum vitae and the names of three references to Dr. Ming Li: mli@unl.edu. For further information about the work that we do, please visit http://www.unl.edu/biopsy. Lincoln, Nebraska, is one of the Midwest's most beloved cities. It offers the exhilaration of a big city and the serenity of the countryside all in one place (www.lincoln.org/).
Ming
Click on this link to unsubscribe from this list UNSUBSCRIBE
An email will automatically open with "Unsubscribe" in the subject area. Just Send the message, as is, to unsubscribe from this list..
2013-09-13
[DIV28SUPER] Dissertation Survey Request
Dear Division 28 Member,My name is Yvona Pabian, M.Ed., a counseling psychology doctoral candidate and a student member of Division 28. I am writing to kindly ask you to participate in my dissertation research conducted under the direction of Elizabeth Reynolds Welfel, Ph.D.
My study seeks to explore psychologists' views on alcohol and other drug (AoD) training and certification, attitudes and practices toward working with substance-using clients, and perceptions of professional support to practice AoD counseling. These topic have taken on increasing importance in light of emerging evidence showing the field's low involvement in AoD counseling and APA's removal of the AoD certificate training program it had sponsored.
The survey should take no more than 10 minutes of your time. As a psychologist with valuable experience, your participation is particularly important to us. You do not have to work primarily in addictions to complete this survey. Your participation in this study may help identify psychologists' AoD workforce development needs, and provide new insights into strategies and policies that may support psychologists' treatment of substance-using clients. Ultimately, the study hopes to contribute knowledge that will improve AoD treatment services.
As a token of our appreciation for your time, we would like to invite you to participate in a raffle for a $100 gift card.
If you are interested in participating, you can click on the survey link below which will take you to the informed consent page. If you consent, you will then be asked to respond to several questions about AoD training, professional support systems, and attitudes and practices with substance-using clients.
Survey link: https://www.surveymonkey.com/s/ZH369SV
If you have any further questions, please call me at (440) 749-2666 or e-mail me at ypabian@me.com. You may also contact Dr. Welfel at welfeler@yahoo.com or (216) 687-4605.
Thank you very much for your time and consideration.
Sincerely,
Yvona L. Pabian, M.Ed. Elizabeth Reynolds Welfel, Ph.D.Doctoral Candidate in Counseling Psychology ProfessorCleveland State University Counseling Psychology Ph.D. ProgramCleveland State University
2013-09-09
[DIV28SUPER] Assistant Research Professor Job Opportunity at Arizona State
------
Arizona State University – Assistant Research Professor, Interdisciplinary Salivary Bioscience Research
Douglas A. Granger PhD
--
Instructor
Johns Hopkins University School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
BPRU Phone: (410) 550-2254
Fax: (410) 550-0030
WARNING: E-mail sent over the Internet is not secure. Information sent by e-mail may not remain confidential.
DISCLAIMER: This e-mail is intended only for the individual to whom it is addressed. It may be used only in accordance with applicable laws. If you received this e-mail by mistake, notify the sender and destroy the e-mail
_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 join our network